Taysha Gene Therapies, Inc. (TSHA)

5.79 +0.03 (+0.52%) USD  |  NASDAQ  |  Dec 12, 16:00
5.795 0.00 (0.00%) After-Hours: 20:00
More

Taysha Gene Therapies EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for TSHA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
AngioDynamics, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade
Bolt Biotherapeutics, Inc. Upgrade
Neurogene, Inc. Upgrade
Aspire Biopharma Holdings, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade